Holen Sie sich die Stockscreener-App
108.72
1.73%
1.85
Schlusskurs vom Vortag:
$106.87
Offen:
$106.71
24-Stunden-Volumen:
1.01M
Relative Volume:
0.91
Marktkapitalisierung:
$6.24B
Einnahmen:
$360.35M
Nettoeinkommen (Verlust:
$-149.57M
KGV:
-36.73
EPS:
-2.96
Netto-Cashflow:
$-81.27M
1W Leistung:
+1.17%
1M Leistung:
+23.06%
6M Leistung:
+13.68%
1J Leistung:
-20.28%
1-Tages-Spanne:
$105.88
$109.38
1-Wochen-Bereich:
$105.88
$112.00
52-Wochen-Spanne:
$73.16
$163.71
Glaukos Corporation Stock (GKOS) Company Profile
Firmenname
Glaukos Corporation
Sektor
Branche
Telefon
949-367-9600
Adresse
1 GLAUKOS WAY, ALISO VIEJO, CA
Vergleichen Sie GKOS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GKOS
Glaukos Corporation
|
108.72 | 6.14B | 360.35M | -149.57M | -81.27M | -2.96 |
|
ABT
Abbott Laboratories
|
122.55 | 210.84B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
92.70 | 137.17B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
353.80 | 133.55B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.77 | 127.71B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.92 | 48.33B | 5.88B | 1.34B | 799.60M | 2.3489 |
Glaukos Corporation Stock (GKOS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-27 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-10-01 | Eingeleitet | Goldman | Buy |
| 2025-05-01 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-02-19 | Hochstufung | Mizuho | Neutral → Outperform |
| 2024-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-12-06 | Eingeleitet | UBS | Buy |
| 2024-12-02 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2024-07-10 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-05-06 | Hochstufung | Jefferies | Hold → Buy |
| 2023-12-21 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-12-04 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2023-11-28 | Eingeleitet | Truist | Buy |
| 2023-11-08 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-06-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-12-22 | Eingeleitet | Mizuho | Neutral |
| 2022-12-19 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2022-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-10-14 | Fortgesetzt | Stephens | Overweight |
| 2022-10-04 | Eingeleitet | Needham | Buy |
| 2022-07-12 | Hochstufung | Stifel | Hold → Buy |
| 2022-02-03 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2022-01-19 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2022-01-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2021-11-03 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2021-07-26 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2021-07-20 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2021-07-14 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2021-07-14 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-04-08 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2021-01-29 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-12-16 | Hochstufung | Citigroup | Sell → Neutral |
| 2020-12-09 | Eingeleitet | Oppenheimer | Perform |
| 2020-11-17 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2020-10-08 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-06-15 | Eingeleitet | Jefferies | Hold |
| 2020-03-05 | Eingeleitet | Citigroup | Sell |
| 2020-02-28 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-01-06 | Hochstufung | Berenberg | Hold → Buy |
| 2019-12-12 | Herabstufung | Wells Fargo | Outperform → Underperform |
| 2019-09-30 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2019-03-08 | Eingeleitet | BTIG Research | Neutral |
| 2018-08-30 | Eingeleitet | Berenberg | Hold |
| 2018-08-29 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-08-03 | Bestätigt | Stifel | Hold |
| 2018-06-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2018-04-13 | Herabstufung | Stifel | Buy → Hold |
| 2018-03-01 | Bestätigt | Cantor Fitzgerald | Buy |
| 2017-03-02 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2017-01-06 | Hochstufung | Stifel | Hold → Buy |
| 2016-10-27 | Eingeleitet | Wells Fargo | Outperform |
Alle ansehen
Glaukos Corporation Aktie (GKOS) Neueste Nachrichten
Glaukos stock price target raised to $125 from $117 at Needham By Investing.com - Investing.com South Africa
Needham Raises Price Target for GKOS, Maintains Buy Rating | GKO - GuruFocus
Trading the Move, Not the Narrative: (GKOS) Edition - news.stocktradersdaily.com
Glaukos price target raised to $125 from $117 at Needham - TipRanks
Needham Adjusts Glaukos Price Target to $125 From $117, Maintains Buy Rating - marketscreener.com
Glaukos stock price target raised to $125 from $117 at Needham - Investing.com India
Marshall Wace LLP Sells 114,086 Shares of Glaukos Corporation $GKOS - MarketBeat
Divisadero Street Capital Management LP Invests $10.51 Million in Glaukos Corporation $GKOS - MarketBeat
Glaukos (NYSE:GKOS) shareholders have earned a 34% CAGR over the last three years - Yahoo Finance
What market sentiment indicators show for Glaukos Corporation stockJuly 2025 Trends & Community Consensus Trade Alerts - Newser
Can Glaukos Corporation stock attract analyst upgradesJuly 2025 Closing Moves & Scalable Portfolio Growth Ideas - Newser
Norges Bank Takes $76.31 Million Position in Glaukos Corporation $GKOS - MarketBeat
Glaukos Corporation $GKOS Shares Sold by Brown Capital Management LLC - MarketBeat
Glaukos Corporation Stock Analysis and ForecastMACD Trading Signals & Rapid Portfolio Expansion - earlytimes.in
Why Glaukos Corporation stock appears on watchlistsWeekly Trade Review & Daily Chart Pattern Signal Reports - Newser
Will Glaukos Corporation (6GJ) stock remain on Wall Street radarJuly 2025 EndofMonth & Precise Entry and Exit Recommendations - Newser
Can Glaukos Corporation (6GJ) stock double in coming yearsForecast Cut & Free Weekly Chart Analysis and Trade Guides - Newser
Is Glaukos Corporation stock a top hedge fund pick2025 Support & Resistance & Short-Term High Return Ideas - Newser
Transcript : Glaukos Corporation Presents at Citi Annual Global Healthcare Conference 2025, Dec-03-2025 01 - marketscreener.com
Granite Investment Partners LLC Has $19.89 Million Stake in Glaukos Corporation $GKOS - MarketBeat
How higher bond yields impact Glaukos Corporation stockMarket Performance Report & High Accuracy Trade Alerts - Newser
Will Glaukos Corporation (6GJ) stock profit from automation waveBreakout Watch & Safe Capital Investment Plans - Newser
Here's Why You Should Retain Glaukos Stock in Your Portfolio - Your Wyoming Link
New York State Common Retirement Fund Increases Stock Position in Glaukos Corporation $GKOS - MarketBeat
Can Glaukos Corporation stock stage a strong rebound this quarter2025 Valuation Update & Fast Exit Strategy with Risk Control - Newser
Glaukos Corporation $GKOS Shares Purchased by Prudential Financial Inc. - MarketBeat
JPMorgan Chase & Co. Buys 59,389 Shares of Glaukos Corporation $GKOS - MarketBeat
Glaukos Corporation $GKOS Shares Sold by Loomis Sayles & Co. L P - MarketBeat
Legal & General Group Plc Boosts Holdings in Glaukos Corporation $GKOS - MarketBeat
Glaukos Corporation $GKOS Shares Purchased by Rhumbline Advisers - MarketBeat
Will Glaukos Corporation stock gain from government policies2025 Investor Takeaways & Entry and Exit Point Strategies - BỘ NỘI VỤ
Glaukos (GKOS) Up 20% Since Last Earnings Report: Can It Continue? - Yahoo Finance
(GKOS) Volatility Zones as Tactical Triggers - news.stocktradersdaily.com
Handelsbanken Fonder AB Reduces Holdings in Glaukos Corporation $GKOS - MarketBeat
Creative Planning Has $1.90 Million Stock Holdings in Glaukos Corporation $GKOS - MarketBeat
Glaukos Corporation $GKOS Shares Purchased by Atika Capital Management LLC - MarketBeat
Alex Thurman Sells 315 Shares of Glaukos (NYSE:GKOS) Stock - MarketBeat
Why Glaukos (GKOS) Is Up 13.9% After iDose Tops Forecasts and 2025 Outlook Rises - simplywall.st
Stifel Nicolaus Sticks to Their Buy Rating for Glaukos (GKOS) - The Globe and Mail
Glaukos Corporation $GKOS Shares Bought by Ensign Peak Advisors Inc - MarketBeat
Stifel reiterates Buy rating on Glaukos stock, maintains $115 price target - Investing.com Canada
Stifel reiterates Buy rating on Glaukos stock, maintains $115 price target By Investing.com - Investing.com South Africa
Why Glaukos Shares Are Facing a Downturn - TipRanks
Glaukos President & COO Joseph Gilliam Sells 39% Of Holding - simplywall.st
Glaukos outlines $600M–$620M 2026 revenue outlook as Epioxa launch and iDose TR drive growth - MSN
FY2025 EPS Estimates for Glaukos Boosted by Zacks Research - MarketBeat
Is Glaukos Corporation stock a safe buy before earningsTrade Risk Assessment & Low Drawdown Investment Ideas - newser.com
Investors Appear Satisfied With Glaukos Corporation's (NYSE:GKOS) Prospects As Shares Rocket 25% - simplywall.st
Will Glaukos Corporation stock benefit from infrastructure spendingWeekly Trading Summary & Daily Profit Focused Stock Screening - newser.com
Why analysts maintain buy rating on Glaukos Corporation stockJuly 2025 Retail & Verified Momentum Watchlists - newser.com
Glaukos gains as Goldman Sachs initiates at Buy on valuation - MSN
Finanzdaten der Glaukos Corporation-Aktie (GKOS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):